Connection

Charlie Strange to Receptors, Platelet-Derived Growth Factor

Back to Details
This is a "connection" page, showing publications Charlie Strange has written about Receptors, Platelet-Derived Growth Factor.
Charlie Strange
Connection Strength
0.575
Receptors, Platelet-Derived Growth Factor
  1. Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease. Eur Respir Rev. 2017 Dec 31; 26(146).
    View in: PubMed
    Score: 0.575
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.